SE9001105D0 - New methods foer diagnosis of tuberculosis - Google Patents

New methods foer diagnosis of tuberculosis

Info

Publication number
SE9001105D0
SE9001105D0 SE9001105A SE9001105A SE9001105D0 SE 9001105 D0 SE9001105 D0 SE 9001105D0 SE 9001105 A SE9001105 A SE 9001105A SE 9001105 A SE9001105 A SE 9001105A SE 9001105 D0 SE9001105 D0 SE 9001105D0
Authority
SE
Sweden
Prior art keywords
tuberculosis
immuno
human
kda protein
diagnosis
Prior art date
Application number
SE9001105A
Other languages
English (en)
Swedish (sv)
Inventor
C Jagannath
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of SE9001105D0 publication Critical patent/SE9001105D0/xx
Priority to SE9001105A priority Critical patent/SE9001105D0/xx
Application filed by Astra Ab filed Critical Astra Ab
Priority to GB9027267A priority patent/GB2239246A/en
Priority to AU68073/90A priority patent/AU6807390A/en
Priority to IE453690A priority patent/IE904536A1/en
Priority to CA002033042A priority patent/CA2033042A1/en
Priority to ZA911855A priority patent/ZA911855B/xx
Priority to IL97572A priority patent/IL97572A0/xx
Priority to JO19911671A priority patent/JO1671B1/en
Priority to PCT/SE1991/000225 priority patent/WO1991014448A1/en
Priority to AU75644/91A priority patent/AU7564491A/en
Priority to BR919105237A priority patent/BR9105237A/pt
Priority to EP91906940A priority patent/EP0479971A1/en
Priority to PT97150A priority patent/PT97150A/pt
Priority to CN91101235A priority patent/CN1060310A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1289—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Mycobacteriaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SE9001105A 1989-12-22 1990-03-27 New methods foer diagnosis of tuberculosis SE9001105D0 (sv)

Priority Applications (14)

Application Number Priority Date Filing Date Title
SE9001105A SE9001105D0 (sv) 1990-03-27 1990-03-27 New methods foer diagnosis of tuberculosis
GB9027267A GB2239246A (en) 1989-12-22 1990-12-17 Protein antigen from Mycobacterium tuberculosis
AU68073/90A AU6807390A (en) 1989-12-22 1990-12-17 New methods of diagnosis of tuberculosis
IE453690A IE904536A1 (en) 1989-12-22 1990-12-17 New methods for diagnosis of tuberculosis
CA002033042A CA2033042A1 (en) 1989-12-22 1990-12-21 Methods for diagnosis of tuberculosis
ZA911855A ZA911855B (en) 1990-03-27 1991-03-13 New methods for diagnosis of tuberculosis
IL97572A IL97572A0 (en) 1990-03-27 1991-03-15 Methods for diagnosis of tuberculosis,means for carrying out such method and novel polypeptides
JO19911671A JO1671B1 (en) 1990-03-27 1991-03-21 New ways to diagnose tuberculosis
EP91906940A EP0479971A1 (en) 1990-03-27 1991-03-22 New proteins, peptides and corresponding dna or rna sequences and probes useful for diagnosing tuberculosis
PCT/SE1991/000225 WO1991014448A1 (en) 1990-03-27 1991-03-22 New proteins, peptides and corresponding dna or rna sequences and probes useful for diagnosing tuberculosis
AU75644/91A AU7564491A (en) 1990-03-27 1991-03-22 New proteins, peptides and corresponding dna or rna sequences and probes useful for diagnosing tuberculosis
BR919105237A BR9105237A (pt) 1990-03-27 1991-03-22 Proteinas,peptidios,sequencias de dna,provas de hibridizacao de dna ou rna,anticorpo,conjunto para realizar imuno-diagnose de tuberculose,microorganismo,vacina contra tuberculose,processo para diagnose de tuberculose humana e provas de dna ou rna
PT97150A PT97150A (pt) 1990-03-27 1991-03-26 Novos metodos para o diagnostico da tuberculose
CN91101235A CN1060310A (zh) 1990-03-27 1991-03-27 用于免疫诊断结核病的新的17KDa蛋白抗原及由其衍生的肽片段的制备方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9001105A SE9001105D0 (sv) 1990-03-27 1990-03-27 New methods foer diagnosis of tuberculosis

Publications (1)

Publication Number Publication Date
SE9001105D0 true SE9001105D0 (sv) 1990-03-27

Family

ID=20379003

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9001105A SE9001105D0 (sv) 1989-12-22 1990-03-27 New methods foer diagnosis of tuberculosis

Country Status (10)

Country Link
EP (1) EP0479971A1 (zh)
CN (1) CN1060310A (zh)
AU (1) AU7564491A (zh)
BR (1) BR9105237A (zh)
IL (1) IL97572A0 (zh)
JO (1) JO1671B1 (zh)
PT (1) PT97150A (zh)
SE (1) SE9001105D0 (zh)
WO (1) WO1991014448A1 (zh)
ZA (1) ZA911855B (zh)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7300660B2 (en) 1993-11-23 2007-11-27 The Regents Of The University Of California Abundant extracellular products and methods for their production and use
US6752993B1 (en) 1993-11-23 2004-06-22 The Regents Of The University Of California Abundant extracellular product vaccines and methods for their production and use
AU1097795A (en) 1993-11-23 1995-06-13 Regents Of The University Of California, The Abundant extracellular products and methods for their production and use
US6458366B1 (en) 1995-09-01 2002-10-01 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
US6290969B1 (en) 1995-09-01 2001-09-18 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6592877B1 (en) 1995-09-01 2003-07-15 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6338852B1 (en) 1995-09-01 2002-01-15 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
US6013660A (en) * 1996-10-02 2000-01-11 The Regents Of The University Of California Externally targeted prophylactic and chemotherapeutic method and agents
US6465633B1 (en) 1998-12-24 2002-10-15 Corixa Corporation Compositions and methods of their use in the treatment, prevention and diagnosis of tuberculosis
CN103063836B (zh) * 2011-10-18 2016-03-30 复旦大学附属华山医院 检测分枝杆菌感染的试剂、方法和试剂盒
CN111518165B (zh) * 2020-05-08 2021-10-01 宁夏大学 一种特异性结合结核分枝杆菌的多肽、其编码基因及应用
CN112125954B (zh) * 2020-09-28 2023-02-28 宁夏医科大学总医院 特异结合卡介苗bcg的七肽、编码基因、制备方法及用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1548388A (en) * 1987-02-02 1988-08-24 Whitehead Institute For Biomedical Research Mycobacterium tuberculosis genes and encoding protein antigens
US4952395A (en) * 1987-02-26 1990-08-28 Scripps Clinic And Research Foundation Mycobacterial recombinants and peptides

Also Published As

Publication number Publication date
PT97150A (pt) 1991-12-31
ZA911855B (en) 1991-12-24
BR9105237A (pt) 1992-07-21
WO1991014448A1 (en) 1991-10-03
CN1060310A (zh) 1992-04-15
EP0479971A1 (en) 1992-04-15
AU7564491A (en) 1991-10-21
JO1671B1 (en) 1992-08-09
IL97572A0 (en) 1992-06-21

Similar Documents

Publication Publication Date Title
Sutherland et al. Acute lymphoblastic leukaemia associated antigen—II. Isolation and partial characterisation
Guilherme et al. Molecular pathogenesis of rheumatic fever and rheumatic heart disease
Gaston et al. Recognition of a mycobacteria-specific epitope in the 65-kD heat-shock protein by synovial fluid-derived T cell clones.
Roebber et al. Immunochemical and genetic studies of Amb. t. V (Ra5G), an Ra5 homologue from giant ragweed pollen.
SE9001105D0 (sv) New methods foer diagnosis of tuberculosis
GR3026419T3 (en) Inducing antibody response against self-proteins with the aid of foreign t-cell epitopes
ATE132197T1 (de) Monoklonale antikörper
US5985277A (en) Antibodies to bacterial stress proteins
UY24130A1 (es) Peptido p277 analogos, y composiciones farmaceuticas que los comprenden para el tratamiento o diagnostico de diabetes.
WO1996021734A3 (en) P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods
BR9106303A (pt) Imonogeno humano composicao,celula de mamifero,peptido,vacina contra sintomas de esclerose multipla,metodo para tratar ou prevenir doenca com sintomas de esclerose multipla e conjunto para diagnosticar esclerose multipla
Alvarenga et al. Induction of neutralizing antibodies against Tityus serrulatus scorpion toxins by immunization with a mixture of defined synthetic epitopes
Blankenhorn et al. Structure of Ia antigens from the rat. Mouse alloantisera demonstrate at least two distinct molecular species
DE3887750D1 (de) Selektive entfernung von immunkomplexen.
JPS6470498A (en) Synthetic peptide and antibody thereto
WO2003012395A3 (en) Early detection of mycobacterial disease using peptides
Ekramoddoullah et al. Partial characterization of an antigenic site of high molecular weight basic antigen, a ryegrass pollen allergen, using a monoclonal antibody
EP0196290A3 (en) Anaplasma marginale subunit antigen for vaccination and diagnosis
Fritz et al. Specificity of antisera from Lewis rats immunized with encephalitogenic fragment 43–88 of guinea pig myelin basic protein
KR970705578A (ko) 신규의 면역피임 펩티드류(new immunocontraceptive peptides)
TH10365EX (th) วิธีการใหม่สำหรับวินิจฉัยวัณโรค
Hajeer et al. Monoclonal antibody epitopes of mycobacterial 65-kD heat-shock protein defined by epitope scanning
CA2109961A1 (en) Peptides for use in induction of t cell activation against hiv-1
SE9000931L (sv) Antikroppar mot proteiner
Shimokawa et al. Lymphocyte chemotaxis in inflammation. VIII. Demonstration of lymphocyte chemotactic lymphokines in PPD-induced delayed hypersensitivity skin reaction site in the guinea-pig.